CRMD Competitors & Alternatives
Compare CorMedix Inc with similar stocks in the same industry
Biotechnology
CRMD
Main Stock$7.55
Tradestie Score
49
Market Cap
$862.55M
P/E Ratio
3.5
Revenue Growth
2.3%
Analyst Upside
+98.7%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.88
|
$665.30M | - | 58 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.84
|
$626.91M | - | 51 | Compare |
|
SVRA
Savara Inc.
|
$5.33
|
$611.84M | - | 58 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
MPLT
MPLT
|
$12.55
|
$590.40M | - | 51 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.17
|
$552.46M | - | 49 | Compare |
|
VSTM
Verastem, Inc.
|
$5.69
|
$541.60M | - | 53 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$13.37
|
$540.97M | - | 50 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$10.06
|
$529.35M | 4.7 | 55 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$111.64
|
$522.78M | - | 51 | Compare |
More CRMD Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry